Mallar Chakravarty is interested in the anatomy of the brain and how it changes through development, aging, and in illness.

Brigitte L. Kieffer, PhD, is the new Scientific Director of the Douglas Institute Research Centre

Carl Ernst studies human behaviour and mood by identifying genes that may be involved in mental disorders.

Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

Michael Meaney examines the molecular mechanisms by which maternal care alters gene expression.

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Sylvain Williams pursues several complimentary lines of study aimed towards elucidating the cause of Alzheimer Disease.